AREDS2 is a randomized trial conducted in more than 80 sites across the U.S. by the National Eye Institute (NEI) of the National Institutes of Health (NIH). This study follows AREDS1, which was published in 2001 and found that people at high risk of developing advanced stages of AMD lowered their risk by about 25 percent when treated with a high-dose combination of vitamin C, vitamin E, beta-carotene, and zinc. AREDS2 assessed the effects of oral supplementation of certain eye nutrients in more than 4,000 participants ranging from 50-85 years of age, most of whom at the time of enrollment had intermediate AMD. It is the largest trial to date testing the effectiveness of lutein, zeaxanthin and omega-3 in adults with AMD. The AREDS2 study also found that circulating blood levels of lutein and zeaxanthin increased significantly in those receiving supplements, which may have a protective effect in eye disease.
About FloraGLO(R) and OPTISHARP(R)
FloraGLO(R) Lutein is manufactured by Kemin, and OPTISHARP(R) Zeaxanthin is manufactured and formulated by DSM. FloraGLO Lutein and OPTISHARP Zeaxanthin are trusted sources of lutein and zeaxanthin because of their quality and established safety profile. Actilease? technology maximizes nutrient absorption to achieve optimum bioavailability.
·Sourced from marigold flowers and purified from marigold flower oleoresin, FloraGLO (R)Lutein is the world's leading patented, purified lutein, manufactured by Kemin and formulated by DSM.
·Identical to the zeaxanthin found in nature, OPTISHARP(R) Zeaxanthin is produced using DSM’s superior formulation technology.
Kemin – Inspired Molecular Solutions?
Kemin (www.kemin.com) provides “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where approximately 500 specialty ingredients are made for the global feed and food industries as well as the health, nutrition and beauty markets. A privately held, family-owned and operated company, Kemin has more than 1,600 employees and operates in 90 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.
FloraGLO(R) is a registered trademark of Kemin Industries, Inc.
OPTISHARP (R) is a registered trademark of DSM
Actilease(R) is a registered trademark of DSM
Copyright:Herbridge Media
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year

